Pharmacolog France has received an order for DrugLog™ to L’Institut du Cancer de Montpellier. The system will be used for the final quality control of chemotherapy preparations at the hospital pharmacy.
Pharmacolog France SARL has received an order for one DrugLog™ system to be placed at L’Institut du Cancer de Montpellier (ICM) in Montpellier, France. This is the third DrugLog™ order received during the last three weeks by Pharmacolog France.
ICM belongs to the Unicancer Group and has been ranked as one of the World’s Best Specialized Hospitals 2021 in the oncology category by Newsweek. The Unicancer Group is a unique model of French hospital federation, exclusively specialized in oncology, ensuring healthcare to more than 530 000 patients each year. ICM brings together about 20 French Comprehensive Cancer Centres, all offering public service and playing a major role in healthcare and research in France.
Mats Högberg, CEO Pharmacolog comments: “This is the third order that our French subsidiary has received in as many weeks. Our French sales manager, Didier Dubois, has, despite challenging conditions during the pandemic, worked purposefully and diligently presenting Pharmacolog solutions to the French speaking markets in Europe and we are now seeing the result of these efforts. The orders are also strong indicators that more and more institutions are investing in solutions for true quality control of their prepared medication. We are all extremely proud and excited to start a collaboration with such a well-reputed institution like ICM.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.
Further information regarding the company is available at http://www.pharmacolog.com.
The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release